With recent studies showing nirsevimab infant immunisation significantly reduced respiratory syncytial virus (RSV)-related hospital admissions, and a maternal vaccine associated with significantly fewer RSV infections in infants, the outlook for RSV prevention in children is encouraging.
No takes yet. Share an insight, caveat, or question.
Priya Venkatesan (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: